Latest News and Press Releases
Want to stay updated on the latest news?
-
ANAHEIM, CA--(Marketwired - Sep 12, 2017) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, today...
-
MISSION VIEJO, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive medicine company which brings objective physical findings to psychiatric treatment in order...
-
TEL AVIV, ISRAEL--(Marketwired - Sep 6, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in...
-
RESTON, Va., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR) and AREVA NP in North America (AREVA Inc.), signed a binding Heads of Terms Agreement for a joint venture (JV)...
-
ATHENS, GREECE--(Marketwired - Aug 30, 2017) - DryShips Inc. (NASDAQ: DRYS), or DryShips or the Company, a diversified owner of ocean going cargo vessels, today announced its unaudited financial...
-
Atinge 15% de crescimento YoY (ano a ano, em inglês), o dobro do mercado de backup e recuperaçãoVendas mundiais do carro-chefe Arcserve Unified Data Protection (UDP) aumentam 28% YoYOrganizações...
-
TEL AVIV, ISRAEL--(Marketwired - Aug 25, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in...
-
TEL AVIV, ISRAEL--(Marketwired - Aug 22, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in...
-
TEL AVIV, ISRAEL--(Marketwired - Aug 22, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus...
-
TEL AVIV, ISRAEL--(Marketwired - Aug 8, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in...